F552 in Alaska. Pick another state for the same tag.
Against expectation — 2025
Alaska cites F552 more often than its own record predicts
Versus expected share1.97×
1.97 times the share F552 takes of citations nationally.
Share of Alaska citations1.06%
Of every deficiency written in Alaska in 2025, this is the portion that was F552.
Alaska1.06%
National0.54%
Share of all citations that were F552.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Alaska surveyors wrote
F552 findings written in Alaska, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
D · No harm, potential for more than minimal, isolatedAugust 14, 2026
.Based on record review and interview, the facility failed to ensure a resident was provided the right to be informed in advance, by the physician or other professional, of the risks and benefits of proposed care, of treatment and treatment alternatives or treatment options and to choose the alternative or option he or she preferred for 1 resident (#7), out 13 residents reviewed for informed consent and psychotropic medication use. Specifically, the facility failed to obtain and document informed consent before Duloxetine (an antidepressant used to treat depression, anxiety, nerve pain, and certain chronic pain conditions) was initiated. …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction